Susceptibility of clinical isolates of Campylobacter pylori to 24 antimicrobial and anti-ulcer agents. 1988

Y Glupczynski, and M Delmee, and C Bruck, and M Labbe, and V Avesani, and A Burette
Department of Microbiology, Brugmann University Hospital, Brussels, Belgium.

Forty-nine isolates of Campylobacter pylori were tested for their susceptibility to twenty antibiotics and four anti-ulcer agents by an agar dilution technique. Penicillin and amoxycillin were the most active drugs (MIC90, 0.06 microgram/ml); erythromycin, cefazolin, minocycline, ciprofloxacin, ofloxacin and gentamicin were slightly less active (MIC90, less than or equal to 1 microgram/ml). Moderate activity was found for doxycyclin, rifampin, nitrofurantoin, norfloxacin, pefloxacin, enoxacin, paromomycin, metronidazole and tinidazole. All strains were resistant to trimethoprim (MIC greater than 512 micrograms/ml). Nalidixic acid (MIC90, greater than 256 micrograms/ml) and colistin (MIC90, greater than 64 micrograms/ml) had little to no activity. Of four anti-ulcer drugs, only bismuth subcitrate showed activity (MIC90, 64 micrograms/ml). Strains resistant to all 4-quinolones were found in patients who had previously received ofloxacin as part of a clinical trial aimed at eradication of C. pylori. These isolates remained susceptible to amoxycillin, tetracyclines and to other classes of antibiotics.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002167 Campylobacter A genus of bacteria found in the reproductive organs, intestinal tract, and oral cavity of animals and man. Some species are pathogenic.
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

Y Glupczynski, and M Delmee, and C Bruck, and M Labbe, and V Avesani, and A Burette
August 1988, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Y Glupczynski, and M Delmee, and C Bruck, and M Labbe, and V Avesani, and A Burette
December 1985, Antimicrobial agents and chemotherapy,
Y Glupczynski, and M Delmee, and C Bruck, and M Labbe, and V Avesani, and A Burette
May 1983, Antimicrobial agents and chemotherapy,
Y Glupczynski, and M Delmee, and C Bruck, and M Labbe, and V Avesani, and A Burette
December 1986, The Journal of antimicrobial chemotherapy,
Y Glupczynski, and M Delmee, and C Bruck, and M Labbe, and V Avesani, and A Burette
October 1989, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Y Glupczynski, and M Delmee, and C Bruck, and M Labbe, and V Avesani, and A Burette
January 2014, Enfermedades infecciosas y microbiologia clinica,
Y Glupczynski, and M Delmee, and C Bruck, and M Labbe, and V Avesani, and A Burette
January 1999, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
Y Glupczynski, and M Delmee, and C Bruck, and M Labbe, and V Avesani, and A Burette
February 1983, Antimicrobial agents and chemotherapy,
Y Glupczynski, and M Delmee, and C Bruck, and M Labbe, and V Avesani, and A Burette
September 1986, Antimicrobial agents and chemotherapy,
Y Glupczynski, and M Delmee, and C Bruck, and M Labbe, and V Avesani, and A Burette
July 1998, The New Zealand medical journal,
Copied contents to your clipboard!